Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash to Debt 4.13
ESMC's Cash to Debt is ranked higher than
53% of the 323 Companies
in the Global Medical Devices industry.

( Industry Median: 3.05 vs. ESMC: 4.13 )
Ranked among companies with meaningful Cash to Debt only.
ESMC' s Cash to Debt Range Over the Past 10 Years
Min: 0.01  Med: 4.51 Max: No Debt
Current: 4.13
Equity to Asset 0.42
ESMC's Equity to Asset is ranked lower than
78% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 0.66 vs. ESMC: 0.42 )
Ranked among companies with meaningful Equity to Asset only.
ESMC' s Equity to Asset Range Over the Past 10 Years
Min: 0.02  Med: 0.57 Max: 0.92
Current: 0.42
0.02
0.92
F-Score: 6
Z-Score: -13.69
M-Score: -2.64
WACC vs ROIC
6.58%
-72.04%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry
vs
history
Operating margin (%) -9.63
ESMC's Operating margin (%) is ranked lower than
60% of the 307 Companies
in the Global Medical Devices industry.

( Industry Median: 2.36 vs. ESMC: -9.63 )
Ranked among companies with meaningful Operating margin (%) only.
ESMC' s Operating margin (%) Range Over the Past 10 Years
Min: -50.06  Med: -10.45 Max: 14.93
Current: -9.63
-50.06
14.93
Net-margin (%) -5.75
ESMC's Net-margin (%) is ranked lower than
59% of the 307 Companies
in the Global Medical Devices industry.

( Industry Median: 0.77 vs. ESMC: -5.75 )
Ranked among companies with meaningful Net-margin (%) only.
ESMC' s Net-margin (%) Range Over the Past 10 Years
Min: -49.85  Med: -5.40 Max: 22.82
Current: -5.75
-49.85
22.82
ROE (%) -25.94
ESMC's ROE (%) is ranked lower than
69% of the 297 Companies
in the Global Medical Devices industry.

( Industry Median: 0.98 vs. ESMC: -25.94 )
Ranked among companies with meaningful ROE (%) only.
ESMC' s ROE (%) Range Over the Past 10 Years
Min: -173.96  Med: -13.62 Max: 117.3
Current: -25.94
-173.96
117.3
ROA (%) -11.41
ESMC's ROA (%) is ranked lower than
62% of the 323 Companies
in the Global Medical Devices industry.

( Industry Median: -0.34 vs. ESMC: -11.41 )
Ranked among companies with meaningful ROA (%) only.
ESMC' s ROA (%) Range Over the Past 10 Years
Min: -45.53  Med: -6.37 Max: 30.83
Current: -11.41
-45.53
30.83
ROC (Joel Greenblatt) (%) -68.43
ESMC's ROC (Joel Greenblatt) (%) is ranked lower than
65% of the 319 Companies
in the Global Medical Devices industry.

( Industry Median: 4.10 vs. ESMC: -68.43 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
ESMC' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -167.54  Med: -47.17 Max: 67.46
Current: -68.43
-167.54
67.46
Revenue Growth (3Y)(%) -18.70
ESMC's Revenue Growth (3Y)(%) is ranked lower than
83% of the 231 Companies
in the Global Medical Devices industry.

( Industry Median: 3.70 vs. ESMC: -18.70 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
ESMC' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -28.6  Med: 0.10 Max: 25.7
Current: -18.7
-28.6
25.7
EBITDA Growth (3Y)(%) -17.30
ESMC's EBITDA Growth (3Y)(%) is ranked lower than
81% of the 198 Companies
in the Global Medical Devices industry.

( Industry Median: 2.30 vs. ESMC: -17.30 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
ESMC' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -58.7  Med: -11.35 Max: 93.5
Current: -17.3
-58.7
93.5
EPS Growth (3Y)(%) -26.30
ESMC's EPS Growth (3Y)(%) is ranked lower than
85% of the 202 Companies
in the Global Medical Devices industry.

( Industry Median: 3.50 vs. ESMC: -26.30 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
ESMC' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -60.1  Med: -7.90 Max: 77.8
Current: -26.3
-60.1
77.8
» ESMC's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q2 2015

ESMC Guru Trades in Q2 2015

Jim Simons 217,500 sh (+0.14%)
» More
Q3 2015

ESMC Guru Trades in Q3 2015

Jim Simons 218,800 sh (+0.60%)
» More
Q4 2015

ESMC Guru Trades in Q4 2015

Jim Simons 220,600 sh (+0.82%)
» More
Q1 2016

ESMC Guru Trades in Q1 2016

Jim Simons 221,700 sh (+0.50%)
» More
» Details

Insider Trades

Latest Guru Trades with ESMC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices
Compare:XSAT:EMOT, ASX:RSH, ROCO:4134, NAS:ETRM, NAS:PHMD, ASX:ALT » details
Traded in other countries:ES4.Germany,
Escalon Medical Corp operates in the healthcare market. The Company is engaged in the development, manufacture, marketing and distribution of medical devices for use in ophthalmology.

Escalon Medical Corp. ( 'Escalon') is a Pennsylvania corporation initially incorporated in California in 1987 and reincorporated in Pennsylvania in November 2001. The Company operates in the healthcare market specializing in the development, manufacture, marketing and distribution of medical devices and pharmaceuticals in the areas of ophthalmology, diabetes, hematology and vascular access. Drew is a diagnostics Company specializing in the design, manufacture and distribution of instruments for blood cell counting and blood analysis. Drew is focused on providing instrumentation and consumables for the physician office and veterinary office laboratories. Drew sells two diabetic testing products: the DS5 and the Hb-Gold. The DS5 instrument, dispenser and associated reagent kit measure long-term glucose control in diabetic patients. Drew offers a array of equipment for use in the field of human and veterinary hematology. Sonomed develops, manufactures and markets ultrasound systems for diagnostic or biometric applications in ophthalmology. The systems are of four types: A-Scans, B-Scans, High Frequency B-Scans ( 'UBMs') and pachymeters. The A-Scan provides information about the internal structure of the eye by sending a beam of ultrasound along a fixed axis through the eye and displaying the various echoes reflected from the surfaces intersected by the beam. The B-Scan is a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque. The UBM is a high frequency/high resolution ultrasound device, designed to provide highly detailed information of the anterior segment of the eye. The pachymeter uses the same principles as the A-Scan, but the system is tailored to measure the thickness of the cornea. The Company distributes two intraocular gas products C3F8 and SF6, which are used by vitreoretinal surgeons as a temporary tamponade in detached retina surgery. The Company conducts development of medical devices for the diagnosis and monitoring of medical disorders in the areas of diabetes, cardiovascular diseases and hematology at the Company's Dallas, Texas, Miami, Florida and Rennes, France facilities. The Company conducts medical device and vascular access product development at its New Berlin, Wisconsin facility. The Company has 13 United States patents and 28 patents issued abroad that cover the Company's surgical products and pharmaceutical technology. The Company's competitors include ophthalmic-oriented companies that market a broad portfolio of products, including prescription ophthalmic pharmaceuticals, ophthalmic devices, consumer products and other eye care products; large integrated pharmaceutical companies that market a limited number of ophthalmic pharmaceuticals in addition to many other pharmaceuticals; and smaller specialty pharmaceutical and biotechnology companies. The Company's products are subject to stringent ongoing regulation by the FDA and similar health authoritie

Ratios

vs
industry
vs
history
P/B 2.68
ESMC's P/B is ranked higher than
55% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 2.69 vs. ESMC: 2.68 )
Ranked among companies with meaningful P/B only.
ESMC' s P/B Range Over the Past 10 Years
Min: 0.3  Med: 1.26 Max: 46.82
Current: 2.68
0.3
46.82
P/S 0.51
ESMC's P/S is ranked higher than
93% of the 295 Companies
in the Global Medical Devices industry.

( Industry Median: 3.12 vs. ESMC: 0.51 )
Ranked among companies with meaningful P/S only.
ESMC' s P/S Range Over the Past 10 Years
Min: 0.21  Med: 0.64 Max: 1.98
Current: 0.51
0.21
1.98
EV-to-EBIT -5.00
ESMC's EV-to-EBIT is ranked lower than
99.99% of the 169 Companies
in the Global Medical Devices industry.

( Industry Median: 21.22 vs. ESMC: -5.00 )
Ranked among companies with meaningful EV-to-EBIT only.
ESMC' s EV-to-EBIT Range Over the Past 10 Years
Min: -32.3  Med: -3.50 Max: 21
Current: -5
-32.3
21
EV-to-EBITDA -5.11
ESMC's EV-to-EBITDA is ranked lower than
99.99% of the 178 Companies
in the Global Medical Devices industry.

( Industry Median: 17.06 vs. ESMC: -5.11 )
Ranked among companies with meaningful EV-to-EBITDA only.
ESMC' s EV-to-EBITDA Range Over the Past 10 Years
Min: -33.4  Med: -4.35 Max: 16.2
Current: -5.11
-33.4
16.2
Current Ratio 2.00
ESMC's Current Ratio is ranked lower than
66% of the 317 Companies
in the Global Medical Devices industry.

( Industry Median: 2.94 vs. ESMC: 2.00 )
Ranked among companies with meaningful Current Ratio only.
ESMC' s Current Ratio Range Over the Past 10 Years
Min: 0.51  Med: 2.57 Max: 6
Current: 2
0.51
6
Quick Ratio 1.02
ESMC's Quick Ratio is ranked lower than
81% of the 317 Companies
in the Global Medical Devices industry.

( Industry Median: 2.10 vs. ESMC: 1.02 )
Ranked among companies with meaningful Quick Ratio only.
ESMC' s Quick Ratio Range Over the Past 10 Years
Min: 0.27  Med: 1.46 Max: 5.29
Current: 1.02
0.27
5.29
Days Inventory 132.35
ESMC's Days Inventory is ranked higher than
51% of the 283 Companies
in the Global Medical Devices industry.

( Industry Median: 136.13 vs. ESMC: 132.35 )
Ranked among companies with meaningful Days Inventory only.
ESMC' s Days Inventory Range Over the Past 10 Years
Min: 77.64  Med: 143.11 Max: 175.88
Current: 132.35
77.64
175.88
Days Sales Outstanding 50.01
ESMC's Days Sales Outstanding is ranked higher than
78% of the 273 Companies
in the Global Medical Devices industry.

( Industry Median: 69.05 vs. ESMC: 50.01 )
Ranked among companies with meaningful Days Sales Outstanding only.
ESMC' s Days Sales Outstanding Range Over the Past 10 Years
Min: 20.07  Med: 49.30 Max: 54.8
Current: 50.01
20.07
54.8
Days Payable 59.90
ESMC's Days Payable is ranked lower than
52% of the 265 Companies
in the Global Medical Devices industry.

( Industry Median: 62.25 vs. ESMC: 59.90 )
Ranked among companies with meaningful Days Payable only.
ESMC' s Days Payable Range Over the Past 10 Years
Min: 15.87  Med: 39.62 Max: 86.2
Current: 59.9
15.87
86.2

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 3.43
ESMC's Price/Net Current Asset Value is ranked higher than
71% of the 211 Companies
in the Global Medical Devices industry.

( Industry Median: 6.66 vs. ESMC: 3.43 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
ESMC' s Price/Net Current Asset Value Range Over the Past 10 Years
Min: 0.83  Med: 2.99 Max: 33.33
Current: 3.43
0.83
33.33
Price/Tangible Book 3.27
ESMC's Price/Tangible Book is ranked higher than
50% of the 273 Companies
in the Global Medical Devices industry.

( Industry Median: 3.55 vs. ESMC: 3.27 )
Ranked among companies with meaningful Price/Tangible Book only.
ESMC' s Price/Tangible Book Range Over the Past 10 Years
Min: 0.61  Med: 2.57 Max: 126.25
Current: 3.27
0.61
126.25
Price/Median PS Value 0.69
ESMC's Price/Median PS Value is ranked higher than
72% of the 265 Companies
in the Global Medical Devices industry.

( Industry Median: 1.01 vs. ESMC: 0.69 )
Ranked among companies with meaningful Price/Median PS Value only.
ESMC' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.32  Med: 1.14 Max: 12.85
Current: 0.69
0.32
12.85
Earnings Yield (Greenblatt) (%) -20.04
ESMC's Earnings Yield (Greenblatt) (%) is ranked lower than
83% of the 318 Companies
in the Global Medical Devices industry.

( Industry Median: 0.80 vs. ESMC: -20.04 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
ESMC' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: -24.01  Med: 216.60 Max: 654.8
Current: -20.04
-24.01
654.8
Forward Rate of Return (Yacktman) (%) 24.69
ESMC's Forward Rate of Return (Yacktman) (%) is ranked higher than
87% of the 115 Companies
in the Global Medical Devices industry.

( Industry Median: 6.77 vs. ESMC: 24.69 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
ESMC' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: -67.7  Med: -6.10 Max: 7.1
Current: 24.69
-67.7
7.1

More Statistics

Revenue (TTM) (Mil) $12.25
EPS (TTM) $ -0.10
Beta0.63
Short Percentage of Float0.01%
52-Week Range $0.71 - 1.55
Shares Outstanding (Mil)7.53
» More Articles for ESMC

Headlines

Articles On GuruFocus.com
Escalon Medical Corp. Reports Operating Results (10-Q) Nov 15 2010 
Escalon Medical Corp. Reports Operating Results (10-K) Oct 12 2010 
Escalon Medical Corp. Reports Operating Results (10-Q) May 20 2010 
Escalon Medical Corp. Reports Operating Results (10-Q) Nov 16 2009 
Escalon Medical Corp. Reports Operating Results (10-Q) May 15 2009 
Escalon Medical Corp. Reports Operating Results (10-Q) Feb 17 2009 

More From Other Websites
ESCALON MEDICAL CORP Financials May 21 2016
Escalon Medical Corp. :ESMC-US: Earnings Analysis: Q3, 2016 By the Numbers May 19 2016
Escalon® Medical Corp. Reports Third Quarter Fiscal 2016 Results May 16 2016
ESCALON MEDICAL CORP Files SEC form 10-Q, Quarterly Report May 16 2016
ESCALON MEDICAL CORP Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued... Mar 07 2016
ESCALON MEDICAL CORP Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued... Feb 23 2016
Escalon Medical Corp. Earnings Analysis: Q2, 2016 By the Numbers Feb 18 2016
/C O R R E C T I O N -- Escalon Medical Corp./ Feb 16 2016
ESCALON MEDICAL CORP Files SEC form 10-Q, Quarterly Report Feb 16 2016
ESCALON MEDICAL CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jan 05 2016
Escalon Medical Corp. Earnings Q1, 2016 Nov 30 2015
Escalon® Medical Corp. Reports First Quarter Fiscal 2016 Results Nov 16 2015
Escalon® Medical Corp. Reports First Quarter Fiscal 2016 Results Nov 16 2015
ESCALON MEDICAL CORP Files SEC form 10-Q, Quarterly Report Nov 16 2015
ESCALON MEDICAL CORP Files SEC form 8-K, Change in Directors or Principal Officers Oct 29 2015
ESCALON MEDICAL CORP Files SEC form 8-K, Change in Directors or Principal Officers Sep 30 2015
ESCALON MEDICAL CORP Files SEC form 10-K/A, Annual Report Sep 29 2015
Escalon® Medical Corp. Reports Fiscal 2015 Results Sep 28 2015
ESCALON MEDICAL CORP Files SEC form 10-K, Annual Report Sep 28 2015
ESCALON MEDICAL CORP Files SEC form 10-Q, Quarterly Report May 14 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)